e-learning
resources
Munich 2014
Wednesday, 10.09.2014
COPD markers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Infective exacerbations of COPD. Relation between the bacteriologic etiology and severity of the disease
A. Ben Saad, N. Rouatbi, N. Skhiri, S. Joobeur, H. Mribah, S. Cheikh Mhamed, A. El Kamel (Monastir, Tunisia)
Source:
International Congress 2014 – COPD markers
Session:
COPD markers
Session type:
Poster Discussion
Number:
4734
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Ben Saad, N. Rouatbi, N. Skhiri, S. Joobeur, H. Mribah, S. Cheikh Mhamed, A. El Kamel (Monastir, Tunisia). Infective exacerbations of COPD. Relation between the bacteriologic etiology and severity of the disease. Eur Respir J 2014; 44: Suppl. 58, 4734
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Impact of frequent exacerbations in patients with COPD
Source: International Congress 2014 – Clinical presentations
Year: 2014
Mukoregulatory drugs in treating COPD
Source: International Congress 2014 – Predictors
Year: 2014
Exacerbations in patients with chronic obstructive lung disease (COPD) and concomitant asthma
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014
Identification of nasal virus infection in patients with COPD exacerbations
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Etiology of exacerbations in severe COPD patients with bronchial chronic colonization by pseudomonas
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Etiological structure from sputum of patients with exacerbation of COPD
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014
Frequency and severity of exacerbations reflect COPD severity, but not COPD phenotype as determined by quantitative CT
Source: International Congress 2014 – Markers
Year: 2014
Are re-admissions with acute exacerbation of chronic obstructive pulmonary disease coded correctly?
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Nutritional status in chronic obstructive pulmonary disease
Source: International Congress 2014 – Comorbidities
Year: 2014
Acute exacerbations of chronic obstructive pulmonary disease: Is it acute exacerbations of chronic cardiopulmonary disease?
Source: International Congress 2014 – Comorbidities
Year: 2014
Factors associated with cognitive dysfunction in COPD patients hospitalised with exacerbations
Source: International Congress 2014 – COPD markers
Year: 2014
Impact of bronchiectasis on duration of hospitalization in patients with exacerbations of COPD
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015
Usefulness of severity predictive scores in COPD exacerbations in hospitalized patients
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Neutrophil CD 64 expression as a diagnostic marker of pneumonia in patients with acute COPD exacerbation
Source: International Congress 2014 – Markers
Year: 2014
Chronic obstructive pulmonary disease exacerbations: Impact of the GOLD stage or the presence of bronchiectasis on sputum microbiology
Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system
Year: 2013
COPD on anti-GERD therapy remains at higher risk for severe exacerbation
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Analysis of the microbiota of sputum samples from patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Role of activated complement in COPD exacerbation recovery
Source: International Congress 2014 – Comorbidities
Year: 2014
Clinical relevance of respiratory pathogens in patients hospitalised with acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013
Distinguishing features of pneumonia and exacerbations in COPD
Source: International Congress 2015 – Prognostic factors in pneumonia: from clinical observations to experimental models
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept